1. A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER). Issue 12 (4th October 2020) Authors: Austin, Cary D.; Gonzalez Edick, Melissa; Ferrando, Ronald E.; Solon, Margaret; Baca, Miriam; Mesh, Kathryn; Bradding, Peter; Gauvreau, Gail M.; Sumino, Kaharu; FitzGerald, J. Mark; Israel, Elliot; Bjermer, Lief; Bourdin, Arnaud; Arron, Joseph R.; Choy, David F.; Olsson, Julie K.; Abreu, Francis;... Journal: Clinical & experimental allergy Issue: Volume 50:Issue 12(2020) Page Start: 1342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗